Co-Diagnostics Inc., a molecular diagnostics company, will attend the 2025 Maxim Growth Summit on October 22-23 at The Hard Rock Hotel NYC. The company will meet with institutional investors in a one-on-one format during the event and participate in discussions with senior Maxim analysts.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA96004) on October 13, 2025, and is solely responsible for the information contained therein.